Small HER2-positive, node-negative breast cancer: who should receive systemic adjuvant treatment? - Publication - Authors - KSSG Research Database

Publication

Small HER2-positive, node-negative breast cancer: who should receive systemic adjuvant treatment?

Journal Paper/Review - Jun 20, 2010

Jörger Markus, Thürlimann Beat, Huober Jens

Jörger, Markus

chief of service
Medizinische Onkologie und Hämatologie · Dept. I

Thürlimann, Beat

Huober, Jens

chief physician
Brustzentrum St.Gallen, Medizinische Onkologie und Hämatologie · Dept. IV, Dept. I